P42 Practical considerations for delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy
| Autor: | Mendell, J., Proud, C., Zaidman, C., Mason, S., Darton, E., Wandel, C., Murphy, A., Mercuri, E., Muntoni, F., McDonald, C. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2023 33 Supplement 1:S69-S69 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect